| answer text |
<p>General practitioners who routinely prescribe dexamethasone for conditions other
than COVID-19 should continue to do so. There is no current or anticipated strain
on the supply of dexamethasone in the United Kingdom.</p><p>Based on findings from
the RECOVERY trial, UK Chief Medical Officers recommend that clinicians consider dexamethasone
for the management of hospitalised patients with COVID-19 who require oxygen or ventilation.
The RECOVERY trial found no benefit for patients who did not require oxygen and the
trial did not study patients outside the hospital setting.</p>
|
 |
